# FDA Inspection 1261246 - Celerion Inc - January 17, 2025

Source: https://www.keypedia.com/records/fda_inspections/celerion-inc/08d60d8d-48db-4cc7-92e4-08541072a9ee
Source feed: FDA_Inspections

> FDA Inspection 1261246 for Celerion Inc on January 17, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261246
- Company Name: Celerion Inc
- Inspection Date: 2025-01-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1261246 - 2025-01-17](https://www.keypedia.com/records/fda_inspections/celerion-inc/e79ee5e6-f2a7-458b-beb6-c1a342867534)
- [FDA Inspection 1114326 - 2019-11-21](https://www.keypedia.com/records/fda_inspections/celerion-inc/c962a5c7-0387-45db-93a9-627df3bb20c3)
- [FDA Inspection 1080997 - 2019-01-11](https://www.keypedia.com/records/fda_inspections/celerion-inc/9f22fffd-33f8-4999-950e-e1b6dda753c6)
- [FDA Inspection 734863 - 2011-06-24](https://www.keypedia.com/records/fda_inspections/celerion-inc/5603e668-1e77-4152-be28-1db2708c9ed1)

Company: https://www.keypedia.com/companies/celerion-inc/9acf3498-a384-487e-8a39-66fd28be03f9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c